• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button Iconcancer treatments

cancer treatments

Rafael E. Carazo Salas, the founder and CEO of CellVoyant
AI
U.K. startup CellVoyant debuts AI platform that could radically reduce the cost of cell-based therapies such as CAR-T immunotherapy for cancer
By Jeremy KahnDecember 18, 2025
A female doctor encourages a young woman with cancer by holding hands on the patient's bed.
AI
The U.S. just bet $1 billion that AI supercomputers can turn most cancers from ‘death sentences’ to ‘manageable conditions’ within 8 years
By Eva RoytburgOctober 28, 2025
Loren Castle, the CEO of Sweet Loren's
Success
Sweet Loren’s CEO was unfulfilled in her ‘real’ jobs—beating cancer gave her the guts to quit and launch the $120 million cookie brand
By Emma BurleighJuly 13, 2025
Exercise, including regular walks, boosts colon cancer survival rates—and even rivals some drugs, study shows
Health
Exercise, including regular walks, boosts colon cancer survival rates—and even rivals some drugs, study shows
By Carla K. Johnson and The Associated PressJune 1, 2025
A woman wearing a head wrap gets a vaccine from a masked doctor
Health
Early mRNA vaccine trial results show potential breakthrough in fighting one of the deadliest cancers
By Beth GreenfieldFebruary 27, 2025
man eating vegetable salad
Health
The number one diet change to lower your cancer risk, according to experts
By Ani FreedmanFebruary 7, 2025
Cancer vaccination, conceptual illustration
Health
Personalized vaccine offers hope for patients with late-stage kidney cancer, clinical trial shows
By Lindsey LeakeFebruary 7, 2025
Entrepreneur and Cost Plus Drugs cofounder Mark Cuban (right) speaks with Andrew Nusca, editorial director of Fortune’s Brainstorm series, at a Brainstorm Tech dinner on Monday, Jan. 6, 2025, in Las Vegas.
Health
Mark Cuban once helped his college friend save almost $10,000 on prescriptions after a ‘horrific car accident’
By Lindsey LeakeJanuary 7, 2025
Lynparza (olaparib), a product of Fortune 500 pharmaceutical firm Merck and Fortune 500 Europe company AstraZeneca, showed meaningful improvements in overall survival in people with germline BRCA-mutated (gBRCAm), HER2-negative high-risk early breast cancer, 2024 clinical trial data suggest.
Health
Merck-AstraZeneca breast cancer drug reduces risk of death by 28% in patients diagnosed early, clinical trial shows
By Lindsey LeakeDecember 20, 2024
Joe Biden walking with a purpose
Health
Biden devotes $150 million to moonshot goal of ending ‘cancer as we know it’
By Will Weissert, Carla K. Johnson and The Associated PressAugust 13, 2024
Cheng "Charlie" Saephan
Health
Cancer patient who won $1.3 billion lottery said he would find a good doctor for himself—’I don’t want to die yet,’ he prayed
By Claire Rush and The Associated PressApril 29, 2024
Super Bowl champion Robin Cole survived prostate cancer but lost loved ones to it. The stigma around treating it has to go, he says—especially among Black men
Commentary
Super Bowl champion Robin Cole survived prostate cancer but lost loved ones to it. The stigma around treating it has to go, he says—especially among Black men
By Robin Cole and Alicia ZhouApril 12, 2024
Many cancer drugs remain unproven 5 years after accelerated approval, a study finds
Health
Many cancer drugs remain unproven 5 years after accelerated approval, a study finds
By Carla K. Johnson and The Associated PressApril 8, 2024
Actress Olivia Munn announced in a March 13, 2024, Instagram post that she had been diagnosed with breast cancer in 2023 and underwent a double mastectomy.
Health
Olivia Munn was diagnosed with breast cancer 2 months after a normal mammogram. This is the tool she says ‘saved my life’
By Lindsey LeakeMarch 13, 2024
Why a biotech firm’s market value jumped from $3 million to $130 million in a day and is still way up from its ‘almost unfathomably low valuation’
Health
Why a biotech firm’s market value jumped from $3 million to $130 million in a day and is still way up from its ‘almost unfathomably low valuation’
By Angel Adegbesan and BloombergOctober 13, 2023
1
  • 1
  • 2
  • 3
3
Most Popular
Success
Mark Cuban says he has the solution to growing income inequality, and it's to reward every employee—from CEO to janitor—with company stockplaceholder alt text
By Sasha RogelbergJuly 20, 2026
Success
‘I want to die broke’: Billionaire philanthropist Denny Sanford dies after giving away $4 billionplaceholder alt text
By Sydney LakeJuly 20, 2026
Cybersecurity
OpenAI says its AI models secretly broke out of a secure test environment and hacked into AI company Hugging Face in order to cheat on an evaluationplaceholder alt text
By Jeremy Kahn and Emily ForliniJuly 21, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.